Search results
Results from the WOW.Com Content Network
D5LR (5% dextrose in lactated Ringer solution) D50 – 50% dextrose in water; The percentage is a mass concentration, so a 5% glucose/dextrose solution contains 50 g/L of glucose/dextrose (5 g per 100 ml). This usage is imprecise but widely used, as discussed at Mass concentration (chemistry) § Usage in biology. Glucose provides energy 4 kcal ...
If the onset of hypernatremia was over a few hours, then it can be corrected relatively quickly using intravenous normal saline and 5% dextrose in water. [1] Otherwise, correction should occur slowly with, for those unable to drink water, half-normal saline. [1]
If overcorrection does occur, a 5% dextrose in water infusion may be given to temporarily lower sodium levels. [2] total of 8 mmol per liter during the first day with the use of furosemide and replacing sodium and potassium losses with 0.9% saline.
Intravenous sugar solutions, such as those containing glucose (also called dextrose), have the advantage of providing some energy, and may thereby provide the entire or part of the energy component of parenteral nutrition. Types of glucose/dextrose include: D5W (5% dextrose in water), which consists of 278 mmol/L dextrose
This page was last edited on 8 March 2014, at 14:49 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may ...
Intravenous therapy (abbreviated as IV therapy) is a medical technique that administers fluids, medications and nutrients directly into a person's vein.The intravenous route of administration is commonly used for rehydration or to provide nutrients for those who cannot, or will not—due to reduced mental states or otherwise—consume food or water by mouth.
Treatment includes administration of intravenous saline to rehydrate and 5% dextrose to turn off gluconeogenesis. Electrolyte imbalances, specifically hypokalaemia, should be corrected. Thiamine supplementation is often included to prevent Wernicke encephalopathy. Insulin is generally not used due to risk of hypoglycemia. [5]
Previously considered universally fatal, the risk of death with adequate and timely treatment is between <1% and 5%. [1] [6] Up to 1% of children with DKA develop a complication known as cerebral edema. [2] Rates of cerebral edema in US children with DKA have risen from 0.4% in 2002 to 0.7% in 2012. [44]